DE69221725D1 - Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen - Google Patents

Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen

Info

Publication number: DE69221725D1
Authority: DE; Germany
Prior art keywords: anorexia; treatment; amylinanalog; composition containing; pct
Prior art date: 1991-05-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69221725T

Other languages

English (en)

Other versions

DE69221725T2 (de

Inventor

Timothy Rink

Andrew Young

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amylin Pharmaceuticals LLC

Original Assignee

Amylin Pharmaceuticals LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-24

Filing date

1992-05-23

Publication date

1997-09-25

1992-05-23 Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC

1997-09-25 Application granted granted Critical

1997-09-25 Publication of DE69221725D1 publication Critical patent/DE69221725D1/de

1997-12-18 Publication of DE69221725T2 publication Critical patent/DE69221725T2/de

2012-05-24 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
102000036770 Islet Amyloid Polypeptide Human genes 0.000 title abstract 3
108010041872 Islet Amyloid Polypeptide Proteins 0.000 title abstract 3
102000004877 Insulin Human genes 0.000 title abstract 2
108090001061 Insulin Proteins 0.000 title abstract 2
208000022531 anorexia Diseases 0.000 title abstract 2
206010061428 decreased appetite Diseases 0.000 title abstract 2
229940125396 insulin Drugs 0.000 title abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE69221725T 1991-05-24 1992-05-23 Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen Expired - Fee Related DE69221725T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US70499591A	1991-05-24	1991-05-24
US86250092A	1992-04-03	1992-04-03
PCT/US1992/004357 WO1992020367A1 (en)	1991-05-24	1992-05-23	Treatment of anorexia and related states

Publications (2)

Publication Number	Publication Date
DE69221725D1 true DE69221725D1 (de)	1997-09-25
DE69221725T2 DE69221725T2 (de)	1997-12-18

Family

ID=27107425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69221725T Expired - Fee Related DE69221725T2 (de)	1991-05-24	1992-05-23	Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen

Country Status (11)

Country	Link
US (1)	US5656590A (de)
EP (1)	EP0586589B1 (de)
JP (1)	JPH06510754A (de)
AT (1)	ATE157010T1 (de)
AU (1)	AU669110B2 (de)
CA (1)	CA2109794A1 (de)
DE (1)	DE69221725T2 (de)
DK (1)	DK0586589T3 (de)
ES (1)	ES2108122T3 (de)
SG (1)	SG49239A1 (de)
WO (1)	WO1992020367A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU222249B1 (hu)	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE69426304T2 (de) *	1993-09-07	2001-03-15	Amylin Pharmaceuticals, Inc.	Methoden zur regulation der den magen und darm betreffenden motilitaet
AUPM678294A0 (en) *	1994-07-13	1994-08-04	Gropep Pty Ltd	Use of insulin-like growth factor in combination with insulin
US5783556A (en) *	1996-08-13	1998-07-21	Genentech, Inc.	Formulated insulin-containing composition
US7910548B2 (en) *	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
US6621131B2 (en) *	2001-11-01	2003-09-16	Intel Corporation	Semiconductor transistor having a stressed channel
CA2509755A1 (en) *	2002-12-27	2004-07-22	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en) *	2002-12-27	2010-02-02	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
WO2005021026A2 (en) *	2003-08-29	2005-03-10	Amylin Pharmaceuticals, Inc.	Methods for treating or ameliorating ghrelin-associated diseases and disorders
WO2007114838A1 (en) *	2006-03-31	2007-10-11	Amylin Pharmaceuticals, Inc.	Amylin and amylin agonists for treating psychiatric diseases and disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8514090D0 (en) *	1985-06-04	1985-07-10	Sandoz Ltd	Organic compounds
JPS61194034A (ja) *	1985-02-25	1986-08-28	Teijin Ltd	経鼻投与用粉末状組成物
US5008241A (en) *	1985-03-12	1991-04-16	Novo Nordisk A/S	Novel insulin peptides
DK119785D0 (da) *	1985-03-15	1985-03-15	Nordisk Gentofte	Insulinpraeparat
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
GB8709871D0 (en) *	1987-04-27	1987-06-03	Turner R C	Peptides
DE3717370A1 (de) *	1987-05-22	1988-12-01	Hoechst Ag	Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4992418A (en) *	1987-07-17	1991-02-12	Mount Sinai School Of Medicine	Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) *	1987-07-17	1991-02-12	Mount Sinai School Of Medicine	Superactive human insulin analogues
US5049547A (en) *	1988-02-11	1991-09-17	University Patents, Inc.	Composition for stimulating integumental melanocytes
GB8915712D0 (en) *	1989-07-08	1989-08-31	Macintyre Iain	Medical treatment
JPH04500688A (ja) *	1989-07-10	1992-02-06	アミリン・コーポレイション	肥満および本態性高血圧および関連疾患の治療
US5016643A (en) *	1990-05-02	1991-05-21	Board Of Regents, The University Of Texas System	Vascular entoptoscope
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
ATE197764T1 (de) *	1991-05-24	2000-12-15	Amylin Pharmaceuticals Inc	Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.

1992
- 1992-05-23 DK DK92913606.7T patent/DK0586589T3/da active
- 1992-05-23 DE DE69221725T patent/DE69221725T2/de not_active Expired - Fee Related
- 1992-05-23 AU AU20115/92A patent/AU669110B2/en not_active Ceased
- 1992-05-23 CA CA002109794A patent/CA2109794A1/en not_active Abandoned
- 1992-05-23 SG SG1996008180A patent/SG49239A1/en unknown
- 1992-05-23 JP JP5500331A patent/JPH06510754A/ja active Pending
- 1992-05-23 US US08/157,003 patent/US5656590A/en not_active Expired - Fee Related
- 1992-05-23 WO PCT/US1992/004357 patent/WO1992020367A1/en not_active Ceased
- 1992-05-23 AT AT92913606T patent/ATE157010T1/de not_active IP Right Cessation
- 1992-05-23 EP EP92913606A patent/EP0586589B1/de not_active Expired - Lifetime
- 1992-05-23 ES ES92913606T patent/ES2108122T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2109794A1 (en)	1992-11-26
DE69221725T2 (de)	1997-12-18
EP0586589B1 (de)	1997-08-20
EP0586589A1 (de)	1994-03-16
ATE157010T1 (de)	1997-09-15
AU669110B2 (en)	1996-05-30
SG49239A1 (en)	1998-05-18
AU2011592A (en)	1992-12-30
ES2108122T3 (es)	1997-12-16
WO1992020367A1 (en)	1992-11-26
US5656590A (en)	1997-08-12
DK0586589T3 (da)	1997-09-22
JPH06510754A (ja)	1994-12-01

Similar Documents

Publication	Publication Date	Title
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE10199020I2 (de)	2004-05-06	Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE185548T1 (de)	1999-10-15	Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
UA42747C2 (uk)	2001-11-15	Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
DE69526937D1 (de)	2002-07-11	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69515183D1 (de)	2000-03-30	Hypolipidämische benzothiazepine
ATE157251T1 (de)	1997-09-15	Verwendung von inositoltriphosphat zur behandlung von entzündungen
EP1040830A4 (de)	2002-10-23	Heilmittel für neurodegenerative krankheiten
DE69324006D1 (de)	1999-04-22	Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung
ATE93138T1 (de)	1993-09-15	Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
ATE165976T1 (de)	1998-05-15	Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
SE9201573D0 (sv)	1992-05-19	Use of igf-1
DE69413829D1 (de)	1998-11-12	Antiglucocorticoidsteroide zur behandlung von angststörungen
DE69221725D1 (de)	1997-09-25	Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
DE59107536D1 (de)	1996-04-18	Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
ATE180669T1 (de)	1999-06-15	Verwendung von pregnanderivaten zur behandlung von tumoren
DE59209728D1 (de)	1999-09-02	VERWENDUNG VON ANTAGONISTEN ODER PARTIELLEN AGONISTEN AM 5-HT 1a-REZEPTOR ZUR BEHANDLUNG UND PRÄVENTION VON KOGNITIVEN STÖRUNGEN
DE69301750D1 (de)	1996-04-18	Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
FI925944A0 (fi)	1992-12-30	Arylalkylestrar av 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-antracenkarboxylsyra med terapeutisk effekt
DE59609977D1 (de)	2003-01-23	Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
ATE128871T1 (de)	1995-10-15	Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
ATE100713T1 (de)	1994-02-15	L-alpha-glycerophosphoryl-d-myoinositol zur behandlung peripherer neuropathien und cerebropathien.
DE69109293D1 (de)	1995-06-01	Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
ATE107165T1 (de)	1994-07-15	Verwendung von macrolactonen als antiallergica.

Legal Events

Date	Code	Title	Description
1998-09-17	8364	No opposition during term of opposition
2010-03-25	8339	Ceased/non-payment of the annual fee